Xiaoying Wang

机构：Zhongshan Hospital · ORCID：0000-0001-5989-1539

发表论文 136 篇 · 总被引 9357 次 · h-index 43

代表论文

• Neutrophil profiling illuminates anti-tumor antigen-presenting potency (2024 · Cell · 被引 436)
• Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma (2024 · Nature Communications · 被引 47)
• Development of a Diagnostic Model for Differentiating Tuberculous Spondylitis and Pyogenic Spondylitis With MRI (2023 · Spine · 被引 19)
• A Transformer‐Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation (2024 · Liver International · 被引 18)
• Defining Global Benchmarks for Robotic Liver Resections (2025 · Annals of Surgery · 被引 9)
• Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 6)